Skip to main navigation Skip to search Skip to main content

United Therapeutics continues to outperform Gilead

Press/Media: Press / Media

PeriodApr 1 2024

Media coverage

9

Media coverage

  • TitleUnited Therapeutics continues to outperform Gilead
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date4/1/24
    PersonsJudith Klein-Seetharaman
  • TitleUnited Therapeutics continues to outperform Amgen
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date4/1/24
    PersonsJudith Klein-Seetharaman
  • TitleUnited Therapeutics continues to outperform Regeneron
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date4/1/24
    PersonsJudith Klein-Seetharaman
  • TitleUnited Therapeutics continues to outperform Vertex Pharmaceuticals
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date4/1/24
    PersonsJudith Klein-Seetharaman
  • TitleUnited Therapeutics's Earnings Growth Lags Gilead
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date4/1/24
    PersonsJudith Klein-Seetharaman
  • TitleUnited Therapeutics's Earnings Growth Lags Regeneron
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date4/1/24
    PersonsJudith Klein-Seetharaman
  • TitleUnited Therapeutics's Earnings Growth Lags Vertex Pharmaceuticals
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date4/1/24
    PersonsJudith Klein-Seetharaman
  • TitleUnited Therapeutics's Earnings Growth Lags Amgen
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date4/1/24
    PersonsJudith Klein-Seetharaman
  • TitleUnited Therapeutics- 7 Reasons Investors Remain Bullish (and 1 Reason Why Bearish)
    Media name/outletGlobal Round Up - Sectors
    Country/TerritoryUnited Kingdom
    Date4/1/24
    PersonsJudith Klein-Seetharaman